SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-134461
Filing Date
2021-04-27
Accepted
2021-04-27 17:12:54
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d179359ddef14a.htm DEF 14A 340742
2 GRAPHIC g179359g0427102316626.jpg GRAPHIC 5278
3 GRAPHIC g179359page040.jpg GRAPHIC 116076
4 GRAPHIC g179359page041.jpg GRAPHIC 99429
  Complete submission text file 0001193125-21-134461.txt   646289
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39425 | Film No.: 21860005
SIC: 2836 Biological Products, (No Diagnostic Substances)